Bioactivity:

Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells. Saikosaponin B2 (5 _M) induces differentiation of B16 melanoma cells, with potentiation of expressions of tyr

CAS nr:

58316-41-9

Purity:

98%

Molecular Weight:

780,99

SMILES:

C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@]4(C)[C@@H]3C=CC3=C5CC(C)(C)CC[C@]5(CO)[C@H](O)C[C@@]43C)[C@]2(C)CO)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O

Formula:

C42H68O13

Pathway:

Microbiology/Virology,Proteases/Proteasome,Others

Target:

HCV Protease,HCV Protease,Others